MedTrace Logo

Pronto-7: Accuracy of Non-invasive Hemoglobin Measurement in Parturients

NCT01893645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2014-09-30

No results posted yet for this study

Summary

The measurement of blood hemoglobin (Hb) concentration is a routine procedure in pregnant women. The assessment of Hb involves several steps, including a needle stick, blood collection, blood sample analysis in the laboratory, and waiting for the results.

Pronto-7 (manufactured by Masimo, CA, USA) is a new portable device that allows a quick bedside Hb spot check. A finger clip probe, similar to the standard oxygen finger clip probe, provides hemoglobin values in less than 60 seconds.

In this prospective observational study the investigators will assess the clinical accuracy of Pronto-7 derived Hb values compared to the gold standard laboratory Hb values in obstetric patients. We will be calculating the mean difference between Pronto-7 and laboratory Hb values. We plan to recruit 55 pregnant women admitted for vaginal or cesarean delivery at BC Women's Hospital.

Conditions

  • Hemoglobin Levels in Blood

Interventions

DEVICE

Pronto-7

A new point-of-care pulse co-oximeter that offers a non-invasive and quick spot-checking of Hb (SpHb).

Sponsors & Collaborators

  • Masimo Corporation

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Vit Gunka, MD · University of British Columbia

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893645 on ClinicalTrials.gov